-
Product Insights
NewInnovations in Magnetic Resonance Imaging (MRI) Contrast Agents – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Magnetic Resonance Imaging (MRI) Contrast Agents - Global Pipeline Summary" provides comprehensive information about the Magnetic Resonance Imaging (MRI) Contrast Agents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Magnetic Resonance Imaging (MRI) Contrast Agents report provides key information and data related to: Extensive coverage of the Magnetic Resonance Imaging (MRI) Contrast Agents under development Review details of major...
-
Sector Analysis
NewMagnetic Resonance Imaging (MRI) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Magnetic Resonance Imaging (MRI) Systems Market Report Overview The MRI systems market size was $5.73 billion in 2023 and will grow at a CAGR of more than 4% during 2023-2033. The increasing prevalence of the aging population and an increase in awareness regarding the importance of early diagnosis of disease which helps in early treatment will fuel the market growth in the coming years. Magnetic Resonance Imaging Systems Market Outlook 2023-2033 ($ Billion) Buy the Full Report for More Insights...
-
Sector Analysis
NewContrast Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Contrast Agents Market Report Overview The contrast agents market size was $3.41 billion in 2023. Factors such as the rising prevalence of chronic diseases and the increased demand for cost-effective and quality healthcare will drive the market growth at a CAGR of more than 2% from 2023 to 2033. Contrast agents are used in radiology to get clearer visualizations of various medical conditions and pathologies. These agents are used with computed tomography (CT), magnetic resonance imaging (MRI), and ultrasounds, among...
-
Sector Analysis
NewContrast Media Injectors Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
The Contrast Media Injectors Market Report Overview The contrast media injectors market size was $1.63 billion in 2023. Factors such as the rising prevalence of chronic diseases and the increased demand for cost-effective and quality healthcare will drive the market growth at a CAGR of more than 4% from 2023 to 2033. Contrast media injectors are devices used to inject contrast media agents into a patient's bloodstream. This process enables the visualization of various pathologies through X-ray, computed tomography, magnetic...
-
Company Insights
NewDecoding Procter & Gamble’s YouTube Advertisement Strategy in Q1 2024
The report on Procter & Gamble's advertising strategies on YouTube during the first quarter of 2024, focus on key products such as Fairy Maxx and Puffs Plus. It analyzes the core themes, messaging strategies, and product benefits portrayed in these advertisements, highlighting elements such as Convenience, Efforless Cleaning, Comfort and Relief benefits. Moreover, the report examines the overarching themes of comfort, quality and sustainability infused into these campaigns. By synthesizing these insights, the report aims to provide a nuanced understanding...
-
Sector Analysis
NewDecoding Apple’s YouTube Advertising Strategy in Q1 2024
This comprehensive report examines Apple Inc.'s advertising strategy on YouTube during January 1 to March 31, 2024. It dissects targeted demographics, core values, and conveyed benefits, emphasizing values like innovation and reliability. Utilizing metrics such as viewership and consumer engagement, the report evaluates the effectiveness of these strategies. It delves into how Apple Inc. communicates its brand values and aims to resonate with its audience. Through thematic approaches, it seeks to establish emotional connections with consumers, providing valuable insights for...
-
Sector Analysis
NewDecoding Samsung’s YouTube Advertising Strategy in Q1 2024
This comprehensive report examines Samsung Electronics Co Ltd, advertising tactics for its products like Galaxy S24 Ultra, Galaxy Book4 Ultra and ViewFinity Monitor from January 1, 2024 to March 31, 2024. It dissects targeted demographics, core values, and conveyed benefits, emphasizing values like innovation and reliability. Utilizing metrics such as viewership and consumer engagement, the report evaluates the effectiveness of these strategies. It delves into how Samsung Electronics Ltd, communicates its brand values and aims to resonate with its audience....
-
Product Insights
NewCanon Medical Systems Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Canon Medical Systems Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Canon Medical Systems Corp (Canon Medical Systems) is a provider of medical diagnostic systems. The company’s major products include computed tomography systems, magnetic resonance imaging systems, ultrasound systems, X-ray; magnetic resonance systems; advanced visualization and nuclear medicine systems. Canon Medical Systems distributes products through subsidiaries and a network of distributors across the world. The company develops medical imaging...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golimumab in Castration-Resistant Prostate Cancer (CRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab in Castration-Resistant Prostate Cancer (CRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golimumab in Castration-Resistant Prostate Cancer (CRPC) Drug Details: Golimumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golimumab in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golimumab in Type 1 Diabetes (Juvenile Diabetes) Drug...